1. Home
  2. BELFB vs GPCR Comparison

BELFB vs GPCR Comparison

Compare BELFB & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

HOLD

Current Price

$242.65

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$47.12

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFB
GPCR
Founded
1949
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
BELFB
GPCR
Price
$242.65
$47.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$174.25
$103.17
AVG Volume (30 Days)
150.6K
568.7K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$491,611,000.00
N/A
Revenue This Year
$9.74
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
$42.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$129.94
$18.49
52 Week High
$335.29
$94.90

Technical Indicators

Market Signals
Indicator
BELFB
GPCR
Relative Strength Index (RSI) 37.27 40.54
Support Level $219.03 $46.40
Resistance Level $248.61 $56.63
Average True Range (ATR) 10.61 2.28
MACD -3.11 -0.76
Stochastic Oscillator 3.26 19.81

Price Performance

Historical Comparison
BELFB
GPCR

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: